首页 > 最新文献

Journal of Thyroid Research最新文献

英文 中文
FRTL-5 Rat Thyroid Cells Release Thyroglobulin Sequestered in Exosomes: A Possible Novel Mechanism for Thyroglobulin Processing in the Thyroid. FRTL-5大鼠甲状腺细胞释放外泌体中隔离的甲状腺球蛋白:甲状腺中甲状腺球蛋白加工的可能新机制
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2016-01-01 Epub Date: 2016-06-09 DOI: 10.1155/2016/9276402
Pavel Vlasov, Sonia Q Doi, Donald F Sellitti

Exosomes are 30-100 nm, membrane-bound vesicles containing specific cellular proteins, mRNAs, and microRNAs that take part in intercellular communication between cells. A possible role for exosomes in thyroid function has not been fully explored. In the present study, FRTL-5 rat thyroid cells were grown to confluence and received medium containing either thyroid stimulating hormone (TSH), exogenous bovine thyroglobulin (bTg), or neither additive for 24 or 48 hours followed by collection of spent medium and ultracentrifugation to isolate small vesicles. Transmission electron microscopy and Western blotting for CD9 indicated the presence of exosomes. Western blotting of exosome extract using a monoclonal anti-Tg antibody revealed a Tg-positive band at ~330 kDa (the expected size of monomeric Tg) with a higher density in TSH-treated cells compared to that in untreated cells. These results are the first to show that normal thyroid cells in culture produce exosomes containing undegraded Tg.

外泌体是30-100 nm的膜结合囊泡,含有特定的细胞蛋白、mrna和microrna,参与细胞间的细胞间通讯。外泌体在甲状腺功能中的可能作用尚未得到充分探讨。本研究将FRTL-5大鼠甲状腺细胞培养至合流状态,并接受含有促甲状腺激素(TSH)、外源性牛甲状腺球蛋白(bTg)或不含任何添加剂的培养基,培养24或48小时,然后收集培养基并进行超离心分离小泡。CD9的透射电镜和Western blotting显示外泌体的存在。使用单克隆抗Tg抗体对外泌体提取物进行Western blotting,发现tsh处理的细胞中有一个约330 kDa(单体Tg的预期大小)的Tg阳性带,与未处理的细胞相比,tsh处理的细胞密度更高。这些结果首次表明,正常的甲状腺细胞在培养中产生含有未降解Tg的外泌体。
{"title":"FRTL-5 Rat Thyroid Cells Release Thyroglobulin Sequestered in Exosomes: A Possible Novel Mechanism for Thyroglobulin Processing in the Thyroid.","authors":"Pavel Vlasov,&nbsp;Sonia Q Doi,&nbsp;Donald F Sellitti","doi":"10.1155/2016/9276402","DOIUrl":"https://doi.org/10.1155/2016/9276402","url":null,"abstract":"<p><p>Exosomes are 30-100 nm, membrane-bound vesicles containing specific cellular proteins, mRNAs, and microRNAs that take part in intercellular communication between cells. A possible role for exosomes in thyroid function has not been fully explored. In the present study, FRTL-5 rat thyroid cells were grown to confluence and received medium containing either thyroid stimulating hormone (TSH), exogenous bovine thyroglobulin (bTg), or neither additive for 24 or 48 hours followed by collection of spent medium and ultracentrifugation to isolate small vesicles. Transmission electron microscopy and Western blotting for CD9 indicated the presence of exosomes. Western blotting of exosome extract using a monoclonal anti-Tg antibody revealed a Tg-positive band at ~330 kDa (the expected size of monomeric Tg) with a higher density in TSH-treated cells compared to that in untreated cells. These results are the first to show that normal thyroid cells in culture produce exosomes containing undegraded Tg. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2016 ","pages":"9276402"},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/9276402","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34636847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Predictors of Regional Lymph Node Recurrence after Initial Thyroidectomy in Patients with Thyroid Cancer. 甲状腺癌患者甲状腺切除术后局部淋巴结复发的预测因素。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2016-01-01 Epub Date: 2016-06-14 DOI: 10.1155/2016/4127278
Amirsina Sharifi, Abolfazl Shojaeifard, Ahmadreza Soroush, Mehdi Jafari, Ali Ghorbani Abdehgah, Hossein Mahmoudzade

Background. Regional lymph node recurrence (RLNR) is common in patients with thyroid cancer but clinicopathological predictors are unclear. We aimed to clarify these predictors and identify patients who would benefit from prophylactic lymph node dissection the most. Method. 343 patients with different types of thyroid cancer were analyzed retrospectively. All patients underwent total thyroidectomy between 2007 and 2013. Results. The median ± interquartile range of patients' age was 40 ± 25 years. 245 (71.4%) patients were female. Regarding the risk of regional lymph node recurrence, we found that male gender, age ≥45 years, non-PTC (i.e., medullary, follicular, and anaplastic types) histopathology, T3 (i.e., tumor size >4 cm in the greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension), stage IVa, and isolated cervical lymphadenopathy as initial manifestation (ICL) are significant risk factors. T3 (p < 0.001; odds ratio = 156.41, 95% CI [55.72-439.1]) and ICL (p < 0.001; odds ratio = 77.79, 95% CI [31.55-191.81]) were the strongest predictors of regional lymph node recurrence. Conclusion. We found easily achievable risk factors for RLNR in thyroid cancers patients. We suggested that patients with specific clinicopathological features like male gender, age ≥45 years, larger tumor size, and extrathyroidal extension be considered as prophylactic lymphadenectomy candidates.

背景。局部淋巴结复发(RLNR)在甲状腺癌患者中很常见,但临床病理预测因素尚不清楚。我们的目的是澄清这些预测因素,并确定从预防性淋巴结清扫中获益最多的患者。方法:对343例不同类型甲状腺癌患者的临床资料进行回顾性分析。所有患者均在2007年至2013年间接受了甲状腺全切除术。结果。患者年龄中位数±四分位数范围为40±25岁。女性245例(71.4%)。关于局部淋巴结复发的风险,我们发现男性、年龄≥45岁、非ptc(即髓样、滤泡型和间变性型)组织病理学、T3(即肿瘤尺寸> 4cm,最大局限于甲状腺或任何甲状腺外扩展最小的肿瘤)、IVa期和孤立性宫颈淋巴结病为初始表现(ICL)是重要的危险因素。T3 (p < 0.001);优势比= 156.41,95% CI[55.72 ~ 439.1])和ICL (p < 0.001;优势比= 77.79,95% CI[31.55 ~ 191.81])是区域淋巴结复发的最强预测因子。结论。我们发现了甲状腺癌患者RLNR容易达到的危险因素。我们建议有特定临床病理特征的患者,如男性、年龄≥45岁、肿瘤体积较大、甲状腺外扩张等,可考虑预防性淋巴结切除术。
{"title":"Predictors of Regional Lymph Node Recurrence after Initial Thyroidectomy in Patients with Thyroid Cancer.","authors":"Amirsina Sharifi,&nbsp;Abolfazl Shojaeifard,&nbsp;Ahmadreza Soroush,&nbsp;Mehdi Jafari,&nbsp;Ali Ghorbani Abdehgah,&nbsp;Hossein Mahmoudzade","doi":"10.1155/2016/4127278","DOIUrl":"https://doi.org/10.1155/2016/4127278","url":null,"abstract":"<p><p>Background. Regional lymph node recurrence (RLNR) is common in patients with thyroid cancer but clinicopathological predictors are unclear. We aimed to clarify these predictors and identify patients who would benefit from prophylactic lymph node dissection the most. Method. 343 patients with different types of thyroid cancer were analyzed retrospectively. All patients underwent total thyroidectomy between 2007 and 2013. Results. The median ± interquartile range of patients' age was 40 ± 25 years. 245 (71.4%) patients were female. Regarding the risk of regional lymph node recurrence, we found that male gender, age ≥45 years, non-PTC (i.e., medullary, follicular, and anaplastic types) histopathology, T3 (i.e., tumor size >4 cm in the greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension), stage IVa, and isolated cervical lymphadenopathy as initial manifestation (ICL) are significant risk factors. T3 (p < 0.001; odds ratio = 156.41, 95% CI [55.72-439.1]) and ICL (p < 0.001; odds ratio = 77.79, 95% CI [31.55-191.81]) were the strongest predictors of regional lymph node recurrence. Conclusion. We found easily achievable risk factors for RLNR in thyroid cancers patients. We suggested that patients with specific clinicopathological features like male gender, age ≥45 years, larger tumor size, and extrathyroidal extension be considered as prophylactic lymphadenectomy candidates. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2016 ","pages":"4127278"},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/4127278","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34724094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations. 胰腺癌甲状腺功能减退:外源性甲状腺激素在肿瘤侵袭中的作用——初步观察。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2016-01-01 Epub Date: 2016-03-31 DOI: 10.1155/2016/2454989
Konrad Sarosiek, Ankit V Gandhi, Shivam Saxena, Christopher Y Kang, Galina I Chipitsyna, Charles J Yeo, Hwyda A Arafat

According to the epidemiological studies, about 4.4% of American general elderly population has a pronounced hypothyroidism and relies on thyroid hormone supplements daily. The prevalence of hypothyroidism in our patients with pancreatic cancer was much higher, 14.1%. A retrospective analysis was performed on patients who underwent pancreaticoduodenectomy (Whipple procedure) or distal pancreatectomy and splenectomy (DPS) at Thomas Jefferson University Hospital, Philadelphia, from 2005 to 2012. The diagnosis of hypothyroidism was correlated with clinicopathologic parameters including tumor stage, grade, and survival. To further understand how thyroid hormone affects pancreatic cancer behavior, functional studies including wound-induced cell migration, proliferation, and invasion were performed on pancreatic cancer cell lines, MiaPaCa-2 and AsPC-1. We found that hypothyroid patients taking exogenous thyroid hormone were more than three times likely to have perineural invasion, and about twice as likely to have higher T stage, nodal spread, and overall poorer prognostic stage (P < 0.05). Pancreatic cancer cell line studies demonstrated that exogenous thyroid hormone treatment increased cell proliferation, migration, and invasion (P < 0.05). We conclude that exogenous thyroid hormone may contribute to the progression of pancreatic cancer.

根据流行病学研究,约4.4%的美国普通老年人患有明显的甲状腺功能减退症,每天需要补充甲状腺激素。我们的胰腺癌患者甲状腺功能减退的患病率要高得多,为14.1%。回顾性分析了2005年至2012年在费城托马斯杰斐逊大学医院接受胰十二指肠切除术(Whipple手术)或远端胰切除术和脾切除术(DPS)的患者。甲状腺功能减退的诊断与临床病理参数相关,包括肿瘤分期、分级和生存。为了进一步了解甲状腺激素如何影响胰腺癌行为,我们对胰腺癌细胞系MiaPaCa-2和AsPC-1进行了功能研究,包括伤口诱导的细胞迁移、增殖和侵袭。我们发现,服用外源性甲状腺激素的甲状腺功能减退患者发生神经周围侵犯的可能性是服用外源性甲状腺激素的患者的3倍以上,发生高T期、淋巴结转移和总体预后不良期的可能性是服用外源性甲状腺激素的患者的2倍左右(P < 0.05)。胰腺癌细胞系研究表明,外源性甲状腺激素治疗增加了细胞的增殖、迁移和侵袭(P < 0.05)。我们得出结论,外源性甲状腺激素可能有助于胰腺癌的进展。
{"title":"Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations.","authors":"Konrad Sarosiek,&nbsp;Ankit V Gandhi,&nbsp;Shivam Saxena,&nbsp;Christopher Y Kang,&nbsp;Galina I Chipitsyna,&nbsp;Charles J Yeo,&nbsp;Hwyda A Arafat","doi":"10.1155/2016/2454989","DOIUrl":"https://doi.org/10.1155/2016/2454989","url":null,"abstract":"<p><p>According to the epidemiological studies, about 4.4% of American general elderly population has a pronounced hypothyroidism and relies on thyroid hormone supplements daily. The prevalence of hypothyroidism in our patients with pancreatic cancer was much higher, 14.1%. A retrospective analysis was performed on patients who underwent pancreaticoduodenectomy (Whipple procedure) or distal pancreatectomy and splenectomy (DPS) at Thomas Jefferson University Hospital, Philadelphia, from 2005 to 2012. The diagnosis of hypothyroidism was correlated with clinicopathologic parameters including tumor stage, grade, and survival. To further understand how thyroid hormone affects pancreatic cancer behavior, functional studies including wound-induced cell migration, proliferation, and invasion were performed on pancreatic cancer cell lines, MiaPaCa-2 and AsPC-1. We found that hypothyroid patients taking exogenous thyroid hormone were more than three times likely to have perineural invasion, and about twice as likely to have higher T stage, nodal spread, and overall poorer prognostic stage (P < 0.05). Pancreatic cancer cell line studies demonstrated that exogenous thyroid hormone treatment increased cell proliferation, migration, and invasion (P < 0.05). We conclude that exogenous thyroid hormone may contribute to the progression of pancreatic cancer. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2016 ","pages":"2454989"},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/2454989","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34439051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Change in Practice over Four Decades in the Management of Graves' Disease in Scotland. 苏格兰四十年来Graves病管理实践的变化
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2016-01-01 Epub Date: 2016-05-30 DOI: 10.1155/2016/9697849
D M Smith, S Dutta, F Ahmed, M A Thaha
There is continuing debate on the optimal treatment for Grave's thyrotoxicosis with a resultant variation in clinical practice. The present study aimed to ascertain changes in practice in the treatment of Grave's thyrotoxicosis in Tayside, Scotland, over the past four decades. Methods. The “Scottish automated follow-up register” (SAFUR) was queried to identify all patients treated for Grave's thyrotoxicosis from 1968 to 2007 inclusive. Patients were divided into 4 groups (Groups A to D) according to the decades. Demographic profile, treatment modalities, radioactive iodine (RAI) dose, and recurrence rates were studied and outcomes were compared by χ 2 test and ANOVA using SPSS v15.0. A p value of < 0.05 was considered significant. Results. Altogether, 3737 patients were diagnosed with Grave's thyrotoxicosis over the 4 decades. Use of RAI has increased from 43.1% in Group A to 68% in Group D (p < 0.001). The dose of RAI has increased (p < 0.001) and there has been a reduction in recurrence rate with higher dose of RAI. Surgical intervention rates decreased from 55.3% to 12.3% (p < 0.001) over time. Conclusions. Analysis of a large dataset of patients with Grave's thyrotoxicosis suggests increasing use of RAI as the preferred first line of treatment. Furthermore, using a single higher dose of RAI and adoption of total thyroidectomy have decreased recurrence rates.
关于格雷夫氏甲状腺毒症的最佳治疗方法,在临床实践中一直存在争议。本研究旨在确定过去四十年来苏格兰泰赛德格雷夫甲状腺毒症治疗实践的变化。方法。对“苏格兰自动随访登记”(SAFUR)进行查询,以确定1968年至2007年期间接受格雷夫甲状腺毒症治疗的所有患者。患者按年龄分为A ~ D组。研究患者的人口学概况、治疗方式、放射性碘(RAI)剂量和复发率,并采用χ(2)检验和方差分析,采用SPSS v15.0进行比较。p值< 0.05为显著性。结果。在过去的40年里,总共有3737名患者被诊断为格雷夫氏甲状腺毒症。RAI的使用率从A组的43.1%上升到D组的68% (p < 0.001)。RAI剂量增加(p < 0.001), RAI剂量越高,复发率越低。随着时间的推移,手术干预率从55.3%下降到12.3% (p < 0.001)。结论。对格雷夫氏甲状腺毒症患者的大型数据集的分析表明,RAI作为首选的一线治疗方法的使用越来越多。此外,使用单一高剂量的RAI和采用甲状腺全切除术可降低复发率。
{"title":"Change in Practice over Four Decades in the Management of Graves' Disease in Scotland.","authors":"D M Smith,&nbsp;S Dutta,&nbsp;F Ahmed,&nbsp;M A Thaha","doi":"10.1155/2016/9697849","DOIUrl":"https://doi.org/10.1155/2016/9697849","url":null,"abstract":"There is continuing debate on the optimal treatment for Grave's thyrotoxicosis with a resultant variation in clinical practice. The present study aimed to ascertain changes in practice in the treatment of Grave's thyrotoxicosis in Tayside, Scotland, over the past four decades. Methods. The “Scottish automated follow-up register” (SAFUR) was queried to identify all patients treated for Grave's thyrotoxicosis from 1968 to 2007 inclusive. Patients were divided into 4 groups (Groups A to D) according to the decades. Demographic profile, treatment modalities, radioactive iodine (RAI) dose, and recurrence rates were studied and outcomes were compared by χ 2 test and ANOVA using SPSS v15.0. A p value of < 0.05 was considered significant. Results. Altogether, 3737 patients were diagnosed with Grave's thyrotoxicosis over the 4 decades. Use of RAI has increased from 43.1% in Group A to 68% in Group D (p < 0.001). The dose of RAI has increased (p < 0.001) and there has been a reduction in recurrence rate with higher dose of RAI. Surgical intervention rates decreased from 55.3% to 12.3% (p < 0.001) over time. Conclusions. Analysis of a large dataset of patients with Grave's thyrotoxicosis suggests increasing use of RAI as the preferred first line of treatment. Furthermore, using a single higher dose of RAI and adoption of total thyroidectomy have decreased recurrence rates.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2016 ","pages":"9697849"},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/9697849","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34650745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Association between Tumor Size and Bilateral Involvement in Papillary Thyroid Carcinoma. 甲状腺乳头状癌肿瘤大小与双侧受累的关系。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2016-01-01 Epub Date: 2016-04-24 DOI: 10.1155/2016/8470252
Suna Erkilic, Fatih Celenk, Zehra Bozdag

Background. Tumor multifocality and bilaterality of papillary thyroid carcinoma (PTC) are important factors when selecting the most appropriate surgical procedure. The aim of this study was to assess the bilaterality rate in PTC and the relationship between the tumor size and bilaterality. Materials and Methods. Thyroidectomy specimens with a diagnosis of PTC were retrospectively reviewed in the Pathology Department of a tertiary care medical center. Specimens were divided into three groups according to the size of the primary and contralateral tumor foci. Tumors less than or equal to 1 cm in each lobe were included in group 1. Group 2 consisted of tumors greater than 1 cm in one lobe and less than 1 cm in the other lobe. Tumors greater than 1 cm in each lobe were included in group 3. Results. We identified 868 total thyroidectomy specimens with a diagnosis of PTC between 2001 and 2011. Of these cases, both thyroid lobes were involved in 262 cases (32%). There were 109 (42%), 121 (46%), and 32 cases (12%) in group 1, group 2, and group 3, respectively. Conclusion. Bilaterality is frequent in PTC and is not related to tumor size. Accordingly, the high frequency of bilateral disease in PTC should be kept in mind when determining the extent of the surgical procedure.

背景。甲状腺乳头状癌(PTC)的多灶性和双侧性是选择最合适的手术方式的重要因素。本研究的目的是评估PTC的双侧发生率以及肿瘤大小与双侧的关系。材料与方法。我们在一家三级医疗中心的病理科回顾了诊断为PTC的甲状腺切除术标本。根据原发和对侧肿瘤病灶大小,将标本分为三组。每叶小于或等于1cm的肿瘤为1组。第二组为一侧肺叶肿瘤大于1cm,另一侧肺叶肿瘤小于1cm。每叶大于1cm的肿瘤为第三组。结果。我们在2001年至2011年间鉴定了868例诊断为PTC的全甲状腺切除术标本。其中双侧甲状腺叶累及262例(32%)。1组109例(42%),2组121例(46%),3组32例(12%)。结论。双侧病变在PTC中很常见,与肿瘤大小无关。因此,在确定手术范围时,应牢记PTC双侧疾病的高频率。
{"title":"Association between Tumor Size and Bilateral Involvement in Papillary Thyroid Carcinoma.","authors":"Suna Erkilic,&nbsp;Fatih Celenk,&nbsp;Zehra Bozdag","doi":"10.1155/2016/8470252","DOIUrl":"https://doi.org/10.1155/2016/8470252","url":null,"abstract":"<p><p>Background. Tumor multifocality and bilaterality of papillary thyroid carcinoma (PTC) are important factors when selecting the most appropriate surgical procedure. The aim of this study was to assess the bilaterality rate in PTC and the relationship between the tumor size and bilaterality. Materials and Methods. Thyroidectomy specimens with a diagnosis of PTC were retrospectively reviewed in the Pathology Department of a tertiary care medical center. Specimens were divided into three groups according to the size of the primary and contralateral tumor foci. Tumors less than or equal to 1 cm in each lobe were included in group 1. Group 2 consisted of tumors greater than 1 cm in one lobe and less than 1 cm in the other lobe. Tumors greater than 1 cm in each lobe were included in group 3. Results. We identified 868 total thyroidectomy specimens with a diagnosis of PTC between 2001 and 2011. Of these cases, both thyroid lobes were involved in 262 cases (32%). There were 109 (42%), 121 (46%), and 32 cases (12%) in group 1, group 2, and group 3, respectively. Conclusion. Bilaterality is frequent in PTC and is not related to tumor size. Accordingly, the high frequency of bilateral disease in PTC should be kept in mind when determining the extent of the surgical procedure. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2016 ","pages":"8470252"},"PeriodicalIF":2.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/8470252","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34572373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Predictors of Thyroid Dysfunction in Patients with HIV Infection and Acquired Immunodeficiency Syndrome: An Indian Perspective 艾滋病毒感染和获得性免疫缺陷综合征患者甲状腺功能障碍的患病率和预测因素:印度视角
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2015-12-22 DOI: 10.1155/2015/517173
N. Sharma, Lokesh Sharma, D. Dutta, A. K. Gadpayle, A. Anand, K. Gaurav, S. Mukherjee, R. Bansal
Background. Predictors of thyroid dysfunction in HIV are not well determined. This study aimed to determine the prevalence and predictors of thyroid dysfunction in HIV infected Indians. Methods. Consecutive HIV patients, 18–70 years of age, without any severe comorbid state, having at least 1-year follow-up at the antiretroviral therapy clinic, underwent clinical assessment and hormone assays. Results. From initially screened 527 patients, 359 patients (61.44 ± 39.42 months' disease duration), having good immune function [CD4 count >200 cell/mm3: 90.25%; highly active antiretroviral therapy (HAART): 88.58%], were analyzed. Subclinical hypothyroidism (ScH) was the commonest thyroid dysfunction (14.76%) followed by sick euthyroid syndrome (SES) (5.29%) and isolated low TSH (3.1%). Anti-TPO antibody (TPOAb) was positive in 3.90%. Baseline CD4 count had inverse correlation with TPOAb after adjusting for age and body mass index. Stepwise linear regression revealed baseline CD4 count, TPOAb, and tuberculosis to be best predictors of ScH after adjusting for age, weight, duration of HIV, and history of opportunistic fungal and viral infections. Conclusion. Burden of thyroid dysfunction in chronic HIV infection with stable immune function is lower compared to pre-HAART era. Thyroid dysfunction is primarily of nonautoimmune origin, predominantly ScH. Severe immunodeficiency at disease onset, TPOAb positivity, and tuberculosis were best predictors of ScH.
背景。HIV患者甲状腺功能障碍的预测因素尚未确定。本研究旨在确定印度HIV感染者甲状腺功能障碍的患病率和预测因素。方法。连续的HIV患者,年龄18-70岁,无任何严重合并症,在抗逆转录病毒治疗诊所随访至少1年,接受临床评估和激素检测。结果。从最初筛选的527例患者中,359例患者(病程61.44±39.42个月)免疫功能良好[CD4计数>200细胞/mm3: 90.25%;高活性抗逆转录病毒治疗(HAART): 88.58%]。亚临床甲状腺功能减退(ScH)是最常见的甲状腺功能障碍(14.76%),其次是病态甲状腺功能正常综合征(SES)(5.29%)和孤立性低TSH(3.1%)。抗tpo抗体(TPOAb)阳性率为3.90%。在调整年龄和体重指数后,基线CD4计数与TPOAb呈负相关。逐步线性回归显示,在调整年龄、体重、HIV持续时间以及机会性真菌和病毒感染史后,基线CD4计数、TPOAb和结核病是ScH的最佳预测因子。结论。与haart前相比,免疫功能稳定的慢性HIV感染者甲状腺功能障碍负担较低。甲状腺功能障碍主要是非自身免疫性的,主要是ScH。发病时严重免疫缺陷、TPOAb阳性和结核病是ScH的最佳预测因子。
{"title":"Prevalence and Predictors of Thyroid Dysfunction in Patients with HIV Infection and Acquired Immunodeficiency Syndrome: An Indian Perspective","authors":"N. Sharma, Lokesh Sharma, D. Dutta, A. K. Gadpayle, A. Anand, K. Gaurav, S. Mukherjee, R. Bansal","doi":"10.1155/2015/517173","DOIUrl":"https://doi.org/10.1155/2015/517173","url":null,"abstract":"Background. Predictors of thyroid dysfunction in HIV are not well determined. This study aimed to determine the prevalence and predictors of thyroid dysfunction in HIV infected Indians. Methods. Consecutive HIV patients, 18–70 years of age, without any severe comorbid state, having at least 1-year follow-up at the antiretroviral therapy clinic, underwent clinical assessment and hormone assays. Results. From initially screened 527 patients, 359 patients (61.44 ± 39.42 months' disease duration), having good immune function [CD4 count >200 cell/mm3: 90.25%; highly active antiretroviral therapy (HAART): 88.58%], were analyzed. Subclinical hypothyroidism (ScH) was the commonest thyroid dysfunction (14.76%) followed by sick euthyroid syndrome (SES) (5.29%) and isolated low TSH (3.1%). Anti-TPO antibody (TPOAb) was positive in 3.90%. Baseline CD4 count had inverse correlation with TPOAb after adjusting for age and body mass index. Stepwise linear regression revealed baseline CD4 count, TPOAb, and tuberculosis to be best predictors of ScH after adjusting for age, weight, duration of HIV, and history of opportunistic fungal and viral infections. Conclusion. Burden of thyroid dysfunction in chronic HIV infection with stable immune function is lower compared to pre-HAART era. Thyroid dysfunction is primarily of nonautoimmune origin, predominantly ScH. Severe immunodeficiency at disease onset, TPOAb positivity, and tuberculosis were best predictors of ScH.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"27 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2015-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79100781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
Thyroid Autoantibodies in the Cerebrospinal Fluid of Subjects with and without Thyroid Disease: Implications for Hashimoto's Encephalopathy 有和没有甲状腺疾病的受试者脑脊液中的甲状腺自身抗体:对桥本脑病的影响
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2015-12-21 DOI: 10.1155/2015/819072
I. Ilias, V. Karagiorga, G. Paraskevas, A. Bougea, Maria Bourbouli, A. Pappa, S. Nikopoulou, E. Kapaki
Introduction. Plasma antithyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies (anti-Tg) are widely used in the diagnosis of autoimmune thyroiditis. No research has compared anti-TPO and anti-Tg both in plasma and cerebrospinal fluid (CSF) of healthy individuals vis-à-vis patients with thyroid disease. Methods. We measured anti-TPO and anti-Tg antibodies in plasma and CSF in nine subjects (mean age ± SD: 73 ± 6 years) with hypothyroidism and nine subjects (mean age ± SD: 73 ± 8 years) without thyroid disease. Results. The concentration of anti-TPO autoantibodies in CSF was very low compared to plasma in both subjects with thyroid and without thyroid disease (P = 0.007). CSF anti-Tg autoantibodies titers were very low compared to the plasma in subjects with thyroid disease (P = 0.004), whereas, in subjects without thyroid disease, this difference did not reach statistical significance (P = 0.063). Conclusions. Thyroid autoantibodies levels were low in plasma and CSF; we did not observe any transfer of thyroid autoantibodies from the peripheral blood to the CSF. Therefore, regarding Hashimoto's encephalopathy, where elevated antithyroid autoantibodies are often measured in blood, it is more likely that thyroiditis and encephalopathy represent nonspecific, but distinct, events of an aggressive immune system.
介绍。血浆抗甲状腺过氧化物酶(anti-TPO)和抗甲状腺球蛋白抗体(anti-Tg)被广泛用于自身免疫性甲状腺炎的诊断。目前还没有研究将健康人血浆和脑脊液中的抗tpo和抗tg与-à-vis甲状腺疾病患者进行比较。方法。我们检测了9例甲状腺功能减退患者(平均年龄±SD: 73±6岁)和9例无甲状腺疾病患者(平均年龄±SD: 73±8岁)血浆和脑脊液中抗tpo和抗tg抗体。结果。与有甲状腺和无甲状腺疾病的受试者相比,脑脊液中抗tpo自身抗体的浓度都很低(P = 0.007)。甲状腺疾病患者脑脊液抗tg自身抗体滴度与血浆相比非常低(P = 0.004),而非甲状腺疾病患者脑脊液抗tg自身抗体滴度与血浆相比差异无统计学意义(P = 0.063)。结论。血浆和脑脊液中甲状腺自身抗体水平低;我们没有观察到甲状腺自身抗体从外周血到脑脊液的任何转移。因此,对于桥本脑病(血液中经常检测到抗甲状腺自身抗体升高),甲状腺炎和脑病更有可能是非特异性的,但不同的,侵袭性免疫系统的事件。
{"title":"Thyroid Autoantibodies in the Cerebrospinal Fluid of Subjects with and without Thyroid Disease: Implications for Hashimoto's Encephalopathy","authors":"I. Ilias, V. Karagiorga, G. Paraskevas, A. Bougea, Maria Bourbouli, A. Pappa, S. Nikopoulou, E. Kapaki","doi":"10.1155/2015/819072","DOIUrl":"https://doi.org/10.1155/2015/819072","url":null,"abstract":"Introduction. Plasma antithyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies (anti-Tg) are widely used in the diagnosis of autoimmune thyroiditis. No research has compared anti-TPO and anti-Tg both in plasma and cerebrospinal fluid (CSF) of healthy individuals vis-à-vis patients with thyroid disease. Methods. We measured anti-TPO and anti-Tg antibodies in plasma and CSF in nine subjects (mean age ± SD: 73 ± 6 years) with hypothyroidism and nine subjects (mean age ± SD: 73 ± 8 years) without thyroid disease. Results. The concentration of anti-TPO autoantibodies in CSF was very low compared to plasma in both subjects with thyroid and without thyroid disease (P = 0.007). CSF anti-Tg autoantibodies titers were very low compared to the plasma in subjects with thyroid disease (P = 0.004), whereas, in subjects without thyroid disease, this difference did not reach statistical significance (P = 0.063). Conclusions. Thyroid autoantibodies levels were low in plasma and CSF; we did not observe any transfer of thyroid autoantibodies from the peripheral blood to the CSF. Therefore, regarding Hashimoto's encephalopathy, where elevated antithyroid autoantibodies are often measured in blood, it is more likely that thyroiditis and encephalopathy represent nonspecific, but distinct, events of an aggressive immune system.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"134 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2015-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88893319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments 放射性碘难治性分化甲状腺癌治疗的患者获益与风险权衡
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2015-11-30 DOI: 10.1155/2015/438235
A. Mohamed, J. González, Angelyn O. Fairchild
Background. The aims of this study were to assess patients' preferences to wait or start systemic treatment and understand how patients would make tradeoffs between certain severe adverse events (AEs) and additional months of progression-free survival (PFS). Materials and Methods. Adults in France, Germany, and Spain with a diagnosis of DTC and who have had at least one RAI treatment completed a direct-elicitation question and a discrete-choice experiment (DCE) online. The direct-elicitation question asked respondents whether they would opt out of treatment when their tumor is RAI-R. In the DCE, respondents chose between 12 pairs of hypothetical RAI-R DTC treatment profiles. Profiles were defined by magnitudes of efficacy (PFS) and safety (severe hand-foot skin reaction [HFSR], severe proteinuria, and severe hypertension). A main-effects random-parameters logit model was estimated. Results. 134 patients completed the survey. Most patients (86.6%) opted for treatment rather than “wait and see” decision. Patients placed a greater weight on the risk of severe hypertension than the risk of proteinuria and HFSR. Conclusions. DTC patients showed preference toward treatment for RAI-R DTC over watchful waiting. Patients' concerns about the risk of severe hypertension appeared to have had a greater effect on patients' choice than severe proteinuria or HFSR.
背景。本研究的目的是评估患者对等待或开始全身治疗的偏好,并了解患者如何在某些严重不良事件(ae)和额外数月的无进展生存期(PFS)之间做出权衡。材料与方法。在法国、德国和西班牙,诊断为DTC并至少接受过一次RAI治疗的成年人在线完成了一个直接启发问题和一个离散选择实验(DCE)。直接启发式问题询问受访者,当他们的肿瘤是rar - r时,他们是否会选择退出治疗。在DCE中,受访者在12对假设的rar - r DTC治疗概况之间进行选择。根据疗效(PFS)和安全性(严重手足皮肤反应[HFSR]、严重蛋白尿和严重高血压)来定义概况。估计了主效应随机参数logit模型。结果:134例患者完成调查。大多数患者(86.6%)选择治疗而不是“观望”决定。患者更重视严重高血压的风险,而不是蛋白尿和HFSR的风险。结论。与观察等待相比,DTC患者更倾向于rar - r DTC治疗。患者对严重高血压风险的担忧似乎比严重蛋白尿或HFSR对患者选择的影响更大。
{"title":"Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments","authors":"A. Mohamed, J. González, Angelyn O. Fairchild","doi":"10.1155/2015/438235","DOIUrl":"https://doi.org/10.1155/2015/438235","url":null,"abstract":"Background. The aims of this study were to assess patients' preferences to wait or start systemic treatment and understand how patients would make tradeoffs between certain severe adverse events (AEs) and additional months of progression-free survival (PFS). Materials and Methods. Adults in France, Germany, and Spain with a diagnosis of DTC and who have had at least one RAI treatment completed a direct-elicitation question and a discrete-choice experiment (DCE) online. The direct-elicitation question asked respondents whether they would opt out of treatment when their tumor is RAI-R. In the DCE, respondents chose between 12 pairs of hypothetical RAI-R DTC treatment profiles. Profiles were defined by magnitudes of efficacy (PFS) and safety (severe hand-foot skin reaction [HFSR], severe proteinuria, and severe hypertension). A main-effects random-parameters logit model was estimated. Results. 134 patients completed the survey. Most patients (86.6%) opted for treatment rather than “wait and see” decision. Patients placed a greater weight on the risk of severe hypertension than the risk of proteinuria and HFSR. Conclusions. DTC patients showed preference toward treatment for RAI-R DTC over watchful waiting. Patients' concerns about the risk of severe hypertension appeared to have had a greater effect on patients' choice than severe proteinuria or HFSR.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"18 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2015-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73097797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Cardiovascular Risk Factors in Subclinical Hypothyroidism: A Case Control Study in Nepalese Population 亚临床甲状腺功能减退的心血管危险因素:尼泊尔人群的病例对照研究
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2015-10-07 DOI: 10.1155/2015/305241
Rajendra Kc, S. Khatiwada, Kishun Deo Mehta, P. Pandey, M. Lamsal, S. Majhi
Objectives. To assess cardiovascular risk factors in Nepalese population with subclinical hypothyroidism as compared to age and sex matched controls. Materials and Methods. A case control study was conducted among 200 subjects (100 subclinical hypothyroid and 100 euthyroid) at B.P. Koirala Institute of Health Sciences, Dharan, Nepal. Demographic and anthropometric variables including systolic and diastolic blood pressure (BP) were taken. Blood samples were assayed for serum free triiodothyronine (fT3), free thyroxine (fT4), thyroid stimulating hormone (TSH), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), and high sensitivity C reactive protein (hs-CRP). Results. Subclinical hypothyroid patients had significantly higher diastolic BP, total cholesterol, LDL cholesterol, and hs-CRP than controls. The odds ratio of having hypercholesterolemia (>200 mg/dL), low HDL cholesterol (<40 mg/dL), undesirable LDL-cholesterol (>100 mg/dL), high hs-CRP (>1 mg/L), and high diastolic BP (>80 mmHg) and being overweight (BMI ≥ 23 Kg/m2) in subclinical hypothyroidism was 2.29 (95% CI; 1.2–4.38, p = 0.011), 1.73 (95% CI; 0.82–3.62, p = 0.141), 3.04 (95% CI; 1.66–5.56, p < 0.001), 2.02 (95% CI; 1.12–3.64, p = 0.018), 3.35 (95% CI; 1.72–6.55, p < 0.001), and 0.9 (95% CI; 0.48–1.67, p = 0.753), respectively, as compared to controls. Conclusion. Subclinical hypothyroid patients are associated with higher risk for cardiovascular disease than euthyroid subjects.
目标。评估尼泊尔亚临床甲状腺功能减退患者的心血管危险因素,并与年龄和性别匹配的对照组进行比较。材料与方法。在尼泊尔达兰B.P.柯伊拉腊健康科学研究所对200名受试者(100名亚临床甲状腺功能减退和100名甲状腺功能正常)进行了病例对照研究。测量人口统计学和人体测量变量,包括收缩压和舒张压(BP)。检测血清游离三碘甲状腺原氨酸(fT3)、游离甲状腺素(fT4)、促甲状腺激素(TSH)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、高敏C反应蛋白(hs-CRP)。结果。亚临床甲状腺功能减退患者的舒张压、总胆固醇、低密度脂蛋白胆固醇和hs-CRP明显高于对照组。亚临床甲状腺功能减退患者高胆固醇血症(>200 mg/dL)、低高密度脂蛋白胆固醇(100 mg/dL)、高hs-CRP (>1 mg/L)、高舒张压(>80 mmHg)和超重(BMI≥23 Kg/m2)的比值比为2.29 (95% CI;1.2-4.38, p = 0.011), 1.73 (95% CI;0.82-3.62, p = 0.141), 3.04 (95% CI;1.66-5.56, p < 0.001), 2.02 (95% CI;1.12-3.64, p = 0.018), 3.35 (95% CI;1.72-6.55, p < 0.001)和0.9 (95% CI;0.48-1.67, p = 0.753)。结论。亚临床甲状腺功能减退患者发生心血管疾病的风险高于甲状腺功能正常者。
{"title":"Cardiovascular Risk Factors in Subclinical Hypothyroidism: A Case Control Study in Nepalese Population","authors":"Rajendra Kc, S. Khatiwada, Kishun Deo Mehta, P. Pandey, M. Lamsal, S. Majhi","doi":"10.1155/2015/305241","DOIUrl":"https://doi.org/10.1155/2015/305241","url":null,"abstract":"Objectives. To assess cardiovascular risk factors in Nepalese population with subclinical hypothyroidism as compared to age and sex matched controls. Materials and Methods. A case control study was conducted among 200 subjects (100 subclinical hypothyroid and 100 euthyroid) at B.P. Koirala Institute of Health Sciences, Dharan, Nepal. Demographic and anthropometric variables including systolic and diastolic blood pressure (BP) were taken. Blood samples were assayed for serum free triiodothyronine (fT3), free thyroxine (fT4), thyroid stimulating hormone (TSH), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), and high sensitivity C reactive protein (hs-CRP). Results. Subclinical hypothyroid patients had significantly higher diastolic BP, total cholesterol, LDL cholesterol, and hs-CRP than controls. The odds ratio of having hypercholesterolemia (>200 mg/dL), low HDL cholesterol (<40 mg/dL), undesirable LDL-cholesterol (>100 mg/dL), high hs-CRP (>1 mg/L), and high diastolic BP (>80 mmHg) and being overweight (BMI ≥ 23 Kg/m2) in subclinical hypothyroidism was 2.29 (95% CI; 1.2–4.38, p = 0.011), 1.73 (95% CI; 0.82–3.62, p = 0.141), 3.04 (95% CI; 1.66–5.56, p < 0.001), 2.02 (95% CI; 1.12–3.64, p = 0.018), 3.35 (95% CI; 1.72–6.55, p < 0.001), and 0.9 (95% CI; 0.48–1.67, p = 0.753), respectively, as compared to controls. Conclusion. Subclinical hypothyroid patients are associated with higher risk for cardiovascular disease than euthyroid subjects.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"23 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2015-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91077188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Bone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT. DXA和HR-pQCT评估长期左甲状腺素替代治疗甲状腺切除术患者的骨指数。
IF 2.1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2015-01-01 Epub Date: 2015-07-13 DOI: 10.1155/2015/796871
Emil Moser, Tanja Sikjaer, Leif Mosekilde, Lars Rejnmark

Background. Studies on bone effects of long-term substitution therapy with levothyroxine (LT4) have shown discrepant results. Previous studies have, however, not evaluated volumetric bone mineral densities (vBMD), bone structure, and strength using high resolution peripheral quantitative computed tomography (HR-pQCT) and finite element analysis (FEA). Using a cross-sectional design, we aimed to determine whether BMD, structure, and strength are affected in hypothyroid patients on LT4 substitution therapy. Methods. We compared 49 patients with well-substituted hypothyroidism with 49 age- and gender-matched population based controls. Areal BMD was assessed by DXA, vBMD and bone geometry by HR-pQCT, and bone strength by FEA. Results. Patients had been thyroidectomized due to thyroid cancer (10%) and nontoxic (33%) or toxic goiter (57%). 82% were women. TSH levels did not differ between groups, but patients had significantly higher levels of T4 (p < 0.001) and lower levels of T3 (p < 0.01). Compared to controls, patients had higher levels of magnesium (p < 0.05), whereas ionized calcium and PTH were lower (p < 0.05). Bone scans did not reveal any differences in BMD, bone geometry, or strength. Conclusion. If patients with hypothyroidism are well-substituted with LT4, the disease does not affect bone indices to any major degree.

背景。关于左旋甲状腺素(LT4)长期替代治疗对骨的影响的研究显示出不同的结果。然而,先前的研究并没有使用高分辨率外围定量计算机断层扫描(HR-pQCT)和有限元分析(FEA)来评估体积骨矿物质密度(vBMD)、骨结构和强度。采用横断面设计,我们旨在确定接受LT4替代治疗的甲状腺功能减退患者的骨密度、结构和强度是否受到影响。方法。我们将49例甲状腺功能减退患者与49例年龄和性别匹配的人群对照进行了比较。采用DXA法评估骨面积骨密度,采用HR-pQCT法评估vBMD和骨几何形状,采用有限元法评估骨强度。结果。患者因甲状腺癌(10%)、无毒(33%)或中毒性甲状腺肿(57%)而行甲状腺切除术。82%是女性。两组间TSH水平无显著差异,但患者T4水平显著升高(p < 0.001), T3水平显著降低(p < 0.01)。与对照组相比,患者镁水平较高(p < 0.05),而离子钙和甲状旁腺激素水平较低(p < 0.05)。骨扫描未显示骨密度、骨几何形状或强度有任何差异。结论。如果甲状腺功能减退患者被LT4很好地替代,则该疾病不会对骨指标产生任何重大影响。
{"title":"Bone Indices in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine Assessed by DXA and HR-pQCT.","authors":"Emil Moser,&nbsp;Tanja Sikjaer,&nbsp;Leif Mosekilde,&nbsp;Lars Rejnmark","doi":"10.1155/2015/796871","DOIUrl":"https://doi.org/10.1155/2015/796871","url":null,"abstract":"<p><p>Background. Studies on bone effects of long-term substitution therapy with levothyroxine (LT4) have shown discrepant results. Previous studies have, however, not evaluated volumetric bone mineral densities (vBMD), bone structure, and strength using high resolution peripheral quantitative computed tomography (HR-pQCT) and finite element analysis (FEA). Using a cross-sectional design, we aimed to determine whether BMD, structure, and strength are affected in hypothyroid patients on LT4 substitution therapy. Methods. We compared 49 patients with well-substituted hypothyroidism with 49 age- and gender-matched population based controls. Areal BMD was assessed by DXA, vBMD and bone geometry by HR-pQCT, and bone strength by FEA. Results. Patients had been thyroidectomized due to thyroid cancer (10%) and nontoxic (33%) or toxic goiter (57%). 82% were women. TSH levels did not differ between groups, but patients had significantly higher levels of T4 (p < 0.001) and lower levels of T3 (p < 0.01). Compared to controls, patients had higher levels of magnesium (p < 0.05), whereas ionized calcium and PTH were lower (p < 0.05). Bone scans did not reveal any differences in BMD, bone geometry, or strength. Conclusion. If patients with hypothyroidism are well-substituted with LT4, the disease does not affect bone indices to any major degree. </p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2015 ","pages":"796871"},"PeriodicalIF":2.1,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2015/796871","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33967126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
期刊
Journal of Thyroid Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1